CD4 and breast cancer: This has been shown in the context of CD4+ T lymphocytes and CD1α dendritic cells in axillary lymph nodes correlating with disease-free survival in breast cancer patients [40], to tumor-infiltrating CD3+ cells and CD8+ T lymphocytes in colon [1] and bladder cancer respectively [2].